180 Life Sciences Corp Inc. (ATNF) Price Performance: The Role of Supply and Demand

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price gain of 31.58% this year. Over the last six months, there has been a weaker performance of 96.08%. The price of ATNF fallen by 240.99% during the last 30 days period. For the last 5-days stocks have improved 59.57%.

180 Life Sciences Corp’s stock has had a calm market performance. The 1-year high for the company’s stock was $17.75 on 10/16/24, and the lowest price during the same period was recorded at $0.66 on 04/09/25.

52-week price history of ATNF Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. 180 Life Sciences Corp’s current trading price is -83.10% away from its 52-week high, while its distance from the 52-week low is 356.07%. The stock’s price range for this period has been between $0.66 and $17.75. The Healthcare sector company’s shares saw a trading volume of about 16.4 million for the day, which was higher than the average daily volume of 1.69 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

180 Life Sciences Corp (ATNF) has experienced a quarterly rise of 248.88% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 18.12M and boasts a workforce of 3 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.08, with a change in price of +1.70. Similarly, 180 Life Sciences Corp recorded 1,249,336 in trading volume during the last 100 days, posting a change of +130.77%.

ATNF’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ATNF stands at 0.26. Similarly, the long-term debt-to-equity ratio is also 0.00.

ATNF Stock Stochastic Average

As of today, the raw stochastic average of 180 Life Sciences Corp over the last 50 days is at 82.73%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 82.73%. Further, the company’s Stochastic %K and %D values for the last 20 days were 63.79% and 60.19%, respectively.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.